High capacity non-viral vectors
View Patent ↗Non-viral vectors for delivering agents to a site within the body of an animal comprise a biocompatible nanoparticle conjugated to an avidin/biotin complex and a water soluble linear polymer comprising multiple binding sites. The agents to be delivered are conjugated to each of the multiple binding sites, thereby increasing the loading capacity of the system. Where the agents comprise siRNA, each biotin/avidin complex may carry greater than four siRNA. The biocompatible nanoparticle may also comprise a fluorescent dye for in vivo imaging.
1. A non-viral vector comprising:
a biocompatible nanoparticle;
an avidin protein conjugated to the biocompatible nanoparticle;
a biotin molecule conjugated to the avidin protein to form an avidin/biotin complex;
a water soluble linear polymer conjugated to the avidin/biotin complex, said water soluble linear polymer comprising a plurality of primary amine functional groups that serve as multiple binding sites; and
a plurality of agents to be delivered to a site within a body of an animal, wherein said plurality of agents are the same or different and are conjugated to the multiple binding sites.
2. The non-viral vector of claim 1 , wherein the plurality of agents are releasably conjugated to the multiple binding sites by a disulfide bond.
3. The non-viral vector of claim 1 , wherein each biotin/avidin complex comprises greater than four agents to be delivered to the site within the body of the animal.
4. The non-viral vector of claim 1 , further comprising a translocation entity comprising a cell penetrating biologic.
5. The non-viral vector of claim 1 , wherein the plurality of agents to be delivered comprise siRNA.
6. The non-viral vector of claim 1 , wherein the biocompatible nanoparticle comprises a fluorescent agent.
7. The non-viral vector of claim 1 , wherein the water soluble linear polymers are selected from the groups consisting of poly (allyl amine), polylysine, chitosan and combinations thereof.
8. The non-viral vector of claim 1 , wherein the non-viral vector comprises a plurality of avidin/biotin complexes and a plurality of water soluble linear polymers capable of carrying between about 500 and about 1000 agents to be delivered to the body of the animal.
9. The non-viral vector of claim 1 , further comprising a cell targeting moiety conjugated to the biotin molecule.